Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2007; 13(27): 3726-3729
Published online Jul 21, 2007. doi: 10.3748/wjg.v13.i27.3726
Published online Jul 21, 2007. doi: 10.3748/wjg.v13.i27.3726
İntestinal typeadenocarcinoma | Diffuse typeadenocarcinoma | Gastric adenocarcinoma(All groups) | İntestinal typeadenocarcinoma | Diffuse typeadenocarcinoma | ||||||
Hp present | Hp absent | Hp present | Hp absent | Alive | Death | Grade 1 | Grade 2 | Grade 3 | Grade 3 | |
Ezrin negative | 4 | 6 | 3 | 10 | 5 | 15 | 0 | 6 | 4 | 13 |
Ezrin positive | 26 | 17 | 4 | 5 | 15 | 18 | 4 | 19 | 20 | 9 |
P | < 0.05 | < 0.05 | > 0.05 |
Intestinal type adenocarcinoma | Diffuse type adenocarcinoma | Intestinal type adenocarcinoma | Diffuse type adenocarcinoma | |||||
With lymphnode metastasis | Without lymphnode metastasis | With lymphnode metastasis | Without lymphnode metastasis | With distantmetastasis | Without distantmetastasis | With distantmetastasis | Without distantmetastasis | |
Ezrin negative | 9 | 1 | 12 | 1 | 1 | 8 | 1 | 12 |
Ezrin positive | 31 | 12 | 8 | 1 | 11 | 31 | 2 | 7 |
P | > 0.05 | > 0.05 |
- Citation: Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselçuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007; 13(27): 3726-3729
- URL: https://www.wjgnet.com/1007-9327/full/v13/i27/3726.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i27.3726